Abstract:Lukana Preechasuk, 1 Suchavadee Tantasuwan, 2 Supawadee Likitmaskul, 1 Jeerunda Santiprabhob, 1, 3 Ornsuda Lertbannaphong, 1, 3 Nattachet Plengvidhya, 2, 4 Watip Tangjittipokin, 4, 5 Wannee Nitiyanant, 1, 2 Raweewan Lertwattanarak 1, 2 1 Siriraj Diabetes Center of Excellence, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; 2 Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; 3 Division of Endocrinology and Metabolism, Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; 4 Siriraj Center of Research Excellence for Diabetes and Obesity, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; 5 Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand Correspondence: Raweewan Lertwattanarak, Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, 2 Wanglang Road, Bangkoknoi, Bangkok, 10700, Thailand, Tel +66 2-419-7799, Fax +66 2-419-7792, Email Purpose: This study aimed to investigate the clinical characteristics, glycemic control, and microvascular complications compared between young-onset type 1 (T1DM) and type 2 diabetes (T2DM) patients at Siriraj Hospital. Patients and Methods: We collected demographic, clinical, glycemic control, and microvascular complication data of young-onset (onset < 30 years of age) T1DM and T2DM patients at our center using February 2019-December 2020 data from the Thai Type 1 Diabetes and Diabetes diagnosed Age before 30 years Registry, Care and Network (T1DDAR CN). Results: Of 396 patients, 76% had T1DM and 24% had T2DM. At diagnosis, T1DM were significantly younger (9.7± 5.4 vs 16.9± 6.4 years, p < 0.001), had a lower body mass index (17.2± 4.1 vs 30.8± 7.9 kg/m 2 , p < 0.001), higher prevalence of diabetic ketoacidosis (DKA) (66.1% vs 13.7%, p < 0.001), and higher HbA 1c level (12.8± 2.6% vs 10.9± 3.1%, p =0.002) compared to T2DM. Regarding glycemic control, the mean HbA 1c at registry enrollment did not differ between groups (T1DM 8.3± 1.8% vs T2DM 8.1± 2.2%, p =0.303), but T1DM achieved HbA 1c < 7% significantly less than T2DM (19.3% vs 47.8%, p < 0.001). T1DM showed deterioration of glycemic control during 10– 20 years of age, and gradually improved during 20– 30 years of age, whereas patients with T2DM showed progressive worsening of glycemic control over time. Concerning microvascular complications, the prevalence of diabetic retinopathy (10.6% vs 9%, p =0.92) and diabetic neuropathy (3.4% vs 5.5%, p =0.514) between T1DM and T2DM was not significantly different. However, T2DM had a significantly higher prevalence of diabetic nephropathy (T1DM 10.1% vs T2DM 40.2%, p < 0.001) that developed within a significantly shorter duration of diabetes (T1DM 11.0± 6.8 vs T2DM 4.3± 5.1 years, p < 0.001) compared to T1DM. Conclusion: T1DM had a significantly high prevalence of DKA at presentation, and most T1DM did not achieve the glycemic target, especially during adolescence. T2DM had a significantly higher prevalence of diabetic nephropathy that developed within a shorter duration of diabetes compared to T1DM. Keywords: clinical characteristics, glycemic control, microvascular complications, young-onset type 1 and type 2 diabetes patients, Siriraj Hospital, Thailand Diabetes is a major health problem that causes a substantial healthcare burden globally. The Global Burden of Disease study reported a global prevalence of diabetes and disability-adjusted life-years associated with diabetes of 476.0 million and 67.9 million in 2017, and those values are projected to increase to 570.9 million and 79.3 million by 2025 – both respectively. 1 The number of children and young adults with diabetes is also increasing annually. The incidence of type 1 diabetes (T1DM) increases by 2–3% per year, and the greatest increase is observed in children aged younger than 15 years. 2 The prevalence of young-onset type 2 diabetes (T2DM), which is usually defined as diabetes onset at an age less than 40 years, is also increasing in most regions of the world – especially in Southeast Asia and the Western Pacific. 3 In Thailand, the incidence of T1DM among children (age range: 0–15 years) increased from 0.2 per 100,000/year in 1984 to 1.65 per 100,000/year in -Abstract Truncated-

Characteristics of Children, Youth, and Young Adults With Diabetes: A Cross‐Sectional Study in New Zealand Aotearoa

Children and adolescents with type 1 diabetes in Aotearoa New Zealand: An online survey of workforce and outcomes 2021

Socioeconomic status and risk factors for complications in young people with type 1 or type 2 diabetes: a cross-sectional study

Clinical Incidence and Characteristics of Newly Diagnosed Type 1 Diabetes in Chinese Children and Adolescents: A Nationwide Registry Study of 34 Medical Centers.

Characteristics and care of young people with type 2 diabetes included in the national diabetes audit datasets for England

Demographic, Clinical, Management, and Outcome Characteristics of 8,004 Young Children With Type 1 Diabetes

Association between age at type 1 diabetes diagnosis and metabolic outcome at young adulthood: a real‐life observational study

Type 2 diabetes in young Indigenous Australians in rural and remote areas: diagnosis, screening, management and prevention

Differences in patient‐reported and clinical characteristics by age group in adults with type 2 diabetes

All-cause, premature, and cardiovascular death attributable to socioeconomic and ethnic disparities among New Zealanders with type 1 diabetes 1994–2019: a multi-linked population-based cohort study

Diabetes Complications among Inpatients with Childhood and Young Adult–Onset Type 1 and 2 Diabetes

Ethnic differences in metabolic achievement between Māori, Pacific, and European New Zealanders with type 2 diabetes

Exploring the Surge in Paediatric Type 2 Diabetes in an Inner-City London Centre—A Decade-Long Analysis of Incidence, Outcomes, and Transition

Experiences of adults with adult-onset type 1 diabetes: a cross-sectional study

Clinical Characteristics, Glycemic Control, and Microvascular Complications Compared Between Young-Onset Type 1 and Type 2 Diabetes Patients at Siriraj Hospital – A Tertiary Referral Center

The changing face of diabetes in youth: lessons learned from studies of type 2 diabetes

Service use and glycaemic control of young people with type 1 diabetes transitioning from paediatric to adult care: a 5‐year study

Diagnosis, treatment and prevention of type 2 diabetes mellitus in children and adolescents

Barriers to Diabetes Self-Management in a Subset of New Zealand Adults with Type 2 Diabetes and Poor Glycaemic Control

Psychological distress in Aotearoa New Zealand adults with type 1 diabetes

Clinical Characterization of Data-Driven Diabetes Clusters of Pediatric Type 2 Diabetes